BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 7, 2021
View Archived Issues
Cosegregation powerfully classifies BRCA 1/2 variants
Read More
A separable microneedle patch improves delivery and storage of COVID-19 DNA nanovaccines
Read More
A large-scale analysis of loss of imprinting in naive and primed human pluripotent stem cells
Read More
Hybrid stem cell spheroids may advance stem cell-based therapies for CNS diseases and disorders
Read More
Researchers develop a murine model of retinal disease
Read More
NR5A2 as pharmacological target for nervous system malignancies
Read More
Purdue Research Foundation patents PD-1/PD-L1 interaction inhibitors
Read More
North China Pharmaceutical Group Semisyntech divulges GPX4 inhibitors
Read More
Zoetis Services identifies IL-1beta, IL-6 and TNF-alpha production inhibitors
Read More
Researchers synthesize new CDK inhibitors
Read More
Verge Analytics discovers new PIKfyve inhibitors
Read More
Study of APOE3 gene variant points to APOE aggregation as a target for treating dementia
Read More
VRDN-002 demonstrates promising PK profile in nonhuman primates
Read More
THRB agonist reduces aggressive phenotype in anaplastic thyroid cancer
Read More
Thymosin beta4 reverses cognitive impairment in mouse model of AD
Read More
RAC1 predicts dabrafenib resistance in papillary thyroid cancer
Read More
Amgen and Neumora collaborate in neuropsychiatric and neurodegenerative diseases
Read More
Chronic myeloid leukemia therapy may be enhanced by ULK1 inhibition
Read More
